Pure Global AI
EUDAMED registration 06972337852369No

Glycated Hemoglobin Analyzer

B&E BIO-TECHNOLOGY CO., LTD.IVD GeneralEU EUDAMEDTrade name: Glycated Hemoglobin Analyzer
VerifiedEUDAMED · official EU database
Device classification
Risk class
IVD General
CND nomenclatures code
W0201060101
Trade name
Glycated Hemoglobin Analyzer
Implantable
No
Reusable
No
Measuring function
No
Registration information
Primary DI
06972337852369
Basic UDI
B-06972337852369
Version date
July 22, 2024
Manufacturer last update
April 25, 2022
Active status
No
Manufacturer
Manufacturer name
B&E BIO-TECHNOLOGY CO., LTD.
Country
China
Country type
NON_EU
Address
No.11 Jieaisi Road,Laishan District,Yantai City Shandong Province
Email
Xinlei.liu@besic.cn
Authorized representative
Name
SUNGO Europe B.V.
SRN
NL-AR-000000247
Country
Netherlands
Address
Fascinatio Boulevard 522, Unit 1.7 Capelle aan den IJssel
Email
ec.rep@sungoglobal.com
Regulatory information
Competent authority
Ministerie van Volksgezondheid, Welzijn en Sport
Applicable legislation
IVDD (Directive 98/79/EC on in vitro Diagnostic Medical Devices)
Placed on the market
Netherlands
Market available
Netherlands:None~None
Device characteristics
Human tissues
No
Animal tissues
No
Device description (EMDN)

GLYCOSILATED HEMOGLOBIN DEVICEs

About this record

Access comprehensive regulatory information for Glycated Hemoglobin Analyzer in the European Union medical device market through Pure Global AI's free database. This IVD General device is registered with EU EUDAMED under Primary DI 06972337852369 and manufactured by B&E BIO-TECHNOLOGY CO., LTD. in China.

This page provides complete registration details including trade name (Glycated Hemoglobin Analyzer), manufacturer information, authorized representative details, competent authority (Ministerie van Volksgezondheid, Welzijn en Sport), and regulatory compliance data from the official EU EUDAMED medical device database. Pure Global AI offers free access to the European Union's complete medical device registry, helping global MedTech companies navigate EU MDR regulations efficiently.